Spontaneous coronary artery dissection (SCAD) is a rare cause of coronary events and sudden cardiac death. SCAD can present with a wide spectrum of clinical presentations and as an entity remains underrecognized. Several risk factors, such as female gender, peripartum and early postpartum state, and atherosclerotic disease, have been attributed to SCAD. Amphetamine use has been attributed to an increased risk for coronary artery events. We present a case of a 22-year-old man on lisdexamfetamine and no other significant medical history who presented with SCAD and was successfully treated with medical management. S pontaneous coronary artery dissection (SCAD) overall remains a relatively rare cause of acute coronary syndromes and tends to aff ect the young healthy population, with a female preponderance. SCAD resulting in acute coronary events has a high mortality rate, and its prompt recognition and treatment is vital. SCAD should be included as part of a complete diff erential in a population with identifi able risk factors. Amphetamines and cocaine have been identifi ed as risk factors for SCAD. Lisdexamfetamine is an amphetamine commonly prescribed for the treatment of attention-defi cit/ hyperactivity disorder (ADHD). We report a case of a 22-yearold on lisdexamfetamine who presented with SCAD and was successfully treated with medical management.
CASE PRESENTATION
A 22-year-old white man with ADHD presented to the emergency department with severe substernal chest pain 8 out of 10 on a pain scale with radiation to his left arm and neck associated with dyspnea, nausea, and vomiting. Th e pain started while he was bicycling and had resolved by the time he arrived at the emergency department. His only home medication was lisdexamfetamine, which he had been taking for about 5 months. He denied any drug or alcohol use, and his drug screen was positive for amphetamines (his prescribed medication). Th e electrocardiogram was normal and his initial troponin level was <0.05 μg/L. An echocardiogram showed ventricular septal hypokinesis with an ejection fraction of 60%. A second troponin test was positive at 2 μg/L and ultimately peaked at 24 μg/L.
Th e patient was started on heparin, aspirin, metoprolol, and clopidogrel and was evaluated with a gated computed tomography coronary angiogram (CTCA). Th e CTCA showed a density concerning for a dissection, with intramural hematoma within the proximal left anterior descending artery (LAD) (Figure 1a, 1b) . Left-sided heart catheterization demonstrated a hazy area in the proximal LAD, consistent with dissection and adherent clot (Figure 1c) . Intravascular ultrasound confi rmed a dissection in the proximal LAD (Figure 1d ). Th ere was TIMI 3 fl ow in the LAD without evidence of compromised fl ow. He was medically treated with aspirin, statin, carvedilol, and lisinopril. Th e lisdexamfetamine was discontinued, and he was cautioned not to start it again. He remained symptom free and was discharged on the above-mentioned medications. At the 1-year mark, he was symptom free and was exercising regularly. Follow-up CTCA at 6 months showed complete resolution of both the dissection and the hematoma.
DISCUSSION
Th is is the fi rst reported case of lisdexamfetamine associated with SCAD. It is unusual for young men to present with coronary dissection (which typically has a female predominance), suggesting that the amphetamine derivative played a role in the pathophysiology (1) . Th ere are isolated cases of methamphetamine causatively associated with SCAD (2). Lisdexamfetamine, an amphetamine-derived stimulant treatment used for ADHD, has been shown to have a safety profi le similar to that of other medications in this group, but has been associated with increased risks of cardiovascular side eff ects (3, 4) .
Notable in this case is that CTCA was used as the initial test in evaluating the patient, especially given the low pretest probability for the presence of coronary disease. It can be a valuable tool in evaluating patients with SCAD (5) .
In this case, as in many cases where SCAD occurs, treatment should be individualized. Patients who are hemodynamically stable, without active symptoms, may be best treated with medications alone. In follow up, as in our case, many of those patients show Spontaneous coronary artery dissection in a 22-year-old man on lisdexamfetamine Aasim M. Afzal, MD, MBA, Syed A. Sarmast, MD, Nicholas A. Weber, BA, and Jeffrey M. Schussler, MD
